Congress just cleared its final fiscal year 2018 spending bill. The bill included $29 million for the National Asthma Control Program (NACP). This program is run by the Centers for Disease Control and Prevention (CDC). This important action reverses the president's proposed cut of nearly $4 million to the program. And it actually gives a slight increase to the NACP above what the program got in the 2017 fiscal year.
On Oct. 1, 2016, Austin Dodds had a massive asthma attack. He lost consciousness and a few days later he passed away. Today, Meredith Dodds is making an impact in her son’s memory and to honor his giving nature. She is raising awareness for asthma.
3 Ways to Keep Spring Celebrations Asthma and Allergy Friendly
The Blue Cross Blue Shield Association (BCBSA) released a report called Childhood Allergies in America. The study showed that allergy rates among children have been going up from 2010 to 2016.
Today, the U.S. Environmental Protection Agency (EPA) awarded more than $8.7 million to replace or retrofit 452 older diesel school buses. The funds are going to 141 school bus fleets in 32 states, each of which will receive rebates through EPA's Diesel Emissions Reduction Act (DERA) funding. The new and retrofitted buses will reduce pollutants that are linked to health problems such as asthma and lung damage.
Access to proper health care coverage is essential and life-saving for people with asthma and allergies. The Asthma and Allergy Foundation of America has joined other patient groups to make up the I Am Essential coalition to advocate against changes that could threaten health care coverage for those we serve. This press release outlines the coalition's concerns about these proposed changes.
Birch trees are known for their tall, thin trunks and white bark. But did you know they trigger a lot of allergy symptoms for much of the population each spring? These allergy symptoms can range from nasal symptoms, like sneezing and a stuffy nose, to the lesser-known oral allergy syndrome (OAS).
Researchers have found that temporarily increasing the dosage of inhaled steroids when asthma symptoms begin to worsen does not effectively prevent severe flare-ups, and may be associated with slowing a child’s growth, challenging a common medical practice involving children with mild-to-moderate asthma.
As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency is reminding consumers to be wary of unapproved products claiming to prevent, treat or cure influenza, or flu. This year’s severe flu season raises new concerns about the potential for consumers to be lured into buying unproven flu treatments, and even worse, buying counterfeit antivirals online from websites that appear to be legitimate online pharmacies.
Asthma and Allergy Foundation of America Study Shows a Higher Burden of Disease for Patients with Adult- and Late Childhood-Onset Atopic Dermatitis vs. Patients with Early Childhood-Onset Atopic Dermatitis WASHINGTON, D.C. (March 4, 2018) - The Asthma and Allergy Foundation of America (AAFA) today announced data demonstrating a higher burden of disease for patients with adult- and late childhood-onset atopic dermatitis (AD) vs patients with early childhood-onset AD. These results are from...
When spring allergy season first starts, causing you to sniffle and sneeze, tree pollen is to blame. Trees start producing pollen as early as January in the Southern U.S. Many trees keep producing pollen through June. What Are the Symptoms of a Tree Pollen Allergy? Pollen allergy symptoms are commonly called “hay fever.” Pollen released by trees, as well as grasses and weeds, cause these symptoms. They include: Runny nose and mucus production Sneezing Itchy nose, eyes, ears and mouth Stuffy...
QVAR® RediHaler™ (beclomethasone dipropionate HFA) Inhalation Aerosol is now available to patients by prescription! It is the first and only breath-actuated inhaled corticosteroid for the maintenance treatment of asthma in patients ages 4 and older. QVAR® RediHaler™ is not used to relieve sudden breathing problems and won’t replace a rescue inhaler.
According to the Food and Drug Administration (FDA), Mylan is discontinuing Aerospan® (80 mcg). Aerospan is a corticosteroid inhaler used for daily asthma maintenance. Mylan notified the FDA on Jan. 26, 2018.
The Asthma and Allergy Foundation of America (AAFA) cautions parents raising children with food allergies that some scenes in the newly-released “Peter Rabbit” film may be disturbing for young viewers with food allergies. In the film, a character with a known food allergy to blackberries is attacked with them. This leads to a severe allergic reaction known as anaphylaxis and the need to use a lifesaving injection of the drug epinephrine.
January flew by and February is already here! It's time to put some of these asthma and allergy tasks on your to-do list for this month.
